Welcome
Please select your view
Featured Pathologist
Dr David Deam
MBBS MAACB FRCPA
Areas of Interest:
Endocrine function testing, protein abnormalities, laboratory automation
Specialities:
Chemical Pathology
Dr Deam graduated with Honours in Medicine from Monash University in 1978 and obtained his FRCPA in 1985, following postgraduate training in Biochemistry at the Royal Melbourne Hospital. After several posts in Chemical Pathology at the Royal Melbourne Hospital and the Royal Women’s Hospital, he was appointed Head of Chemical Pathology at the Royal Melbourne in 1996. He joined Gribbles Pathology (now Australian Clinical Labs) in 1998. Dr Deam has played an active role in teaching scientific, nursing and medical staff at both undergraduate and postgraduate levels and has been an examiner for the Australasian Association of Clinical Biochemists as well as the Royal College of Pathologists of Australasia. Dr Deam’s research interests and publications include work on thyroid function testing, various aspects of diagnostic protein measurement and the rational use of biochemical tests.
Dr Tony Mak
MBBS MBA FRCPA FRCPath
Areas of Interest:
Toxicology
Specialities:
Chemical Pathology
Dr Tony Mak is a chemical pathologist who graduated from the medical school of the Chinese University of Hong Kong. Before migrating to Australia, Tony worked as a consultant chemical pathologist at Princess Margaret Hospital – a major acute district general hospital in Hong Kong. Tony founded, developed, and operated the highest level clinical toxicology laboratory in Hong Kong. He led his team to develop numerous useful analyses to solve many difficult clinical toxicology problems with public health implications, including Chinese medicine-related poisoning, plant-related poisoning, novel psychoactive substances, slimming agents and related problems, drug adulteration and counterfeit drugs. Tony held numerous management roles in Hong Kong including Head of the Department of Pathology, Service Director (Quality and Safety) and Deputy Hospital Chief Executive. He has published more than 100 articles in international peer-reviewed academic journals and a number of books. Tony recently joined Clinical Labs as the Clinical Director of Chemical Pathology for Clinical Labs in WA.
Assoc. Prof. Louise Smyth
BA MBBS GCUT DipHPE FRCPA
Areas of Interest:
Autoimmunity, transplantation, immune deficiency, allergy
Specialities:
Allergy and Immunology
Associate Professor Smyth is a graduate of the University of Western Australia and a Fellow of, and former state representative of the RCPA. Associate Professor Smyth designed and implemented the Pathology programme for the School of Medicine at the University of Notre Dame Australia, Fremantle where she is a founding member of, and Associate Professor in the School of Medicine. She has a Graduate Certificate in University Teaching, qualifying her to supervise candidates for higher degrees as well as teaching undergraduate students. She is most interested in autoimmunity but has extensive experience including autoimmunity, transplantation, immune deficiency and allergy. Her publications are predominantly in the field of Bone Marrow Transplantation. Dr Smyth joined St John of God Pathology (now Australian Clinical Labs) in 2016.
Dr Wessel Jenner
BSc MBChB FRCPA
Areas of Interest:
Chemical pathology, endocrinology, and proteins
Specialities:
Biochemistry, Chemical Pathology
Dr Jenner completed his studies in chemistry and biochemistry in 1992 followed by a Bachelor’s degree in Medicine and Surgery (MBChB) from the Faculty of Health Sciences, University of Pretoria, South Africa in 1997. Following three years of clinical practice, he commenced training in Chemical Pathology in 2001 and obtained the Fellowship from the Colleges of Medicine of South Africa in 2004 and a Master’s degree in Chemical Pathology from the University of Pretoria in 2005. Later that year Dr Jenner moved to the UK where he worked as senior registrar in Clinical Biochemistry at the Royal Infirmary of Edinburgh and then as Consultant Clinical Biochemist at the NHS Borders Hospital (Scotland) for a few years. Following a return to South Africa he held a position as consultant chemical pathologist in private practice for five years. In 2012 he relocated to Australia and worked as a senior registrar at the Royal Brisbane and Women’s Hospital. Dr Jenner obtained his Fellowship from the Royal College of Pathologists of Australasia in 2013 and joined Australian Clinical Labs (formerly Healthscope Pathology) in early 2014.
Assoc. Prof. Mirette Saad
MBBS (Hons) MD (Hons) MAACB FRCPA PhD
Areas of Interest:
Molecular genetics, precision medicine, cancer genetics, antenatal screening, NIPT, endocrine, fertility testing and research, medical teaching
Specialities:
Chemical Pathology
Australian Clinical Labs. She has a Fellowship with honours in Chemical and Molecular Pathology, with Microbiology sub-speciality, from Suez Canal University, Egypt. A/P Saad received her NHMRC sponsored PhD degree in Cancer Genetics from Melbourne University and Peter MacCallum Cancer Institute. Along with her teaching and research roles, A/P Saad is a registered medical practitioner with AHPRA, a Chemical Pathology Fellow (FRCPA) at the Royal College of Pathologists of Australasia and a Member of the Australasian Association of Clinical Biochemists (MAACB). She is a Chair of the RCPA Chemical Pathology Advisory Committee, Member of the RCPA Genetic Advisory Committee, AACB and a Chair of the Precision Medicine Services at Australian Clinical Labs. At Clinical Labs, A/Prof Mirette Saad leads the Molecular Genetic testing for non-invasive prenatal testing (NIPT), antenatal screening, personalised drug therapy and cancer.
News
-
Acquisition of Medlab Pathology by Australian Clinical Labs to Further Strengthen National Scale
ACL today announced that it had entered into a binding agreement to purchase Medlab Pathology (Medlab).
-
COVID-19 Testing for Organisations
Due to an increase in demand for asymptomatic testing across Australia, Clinical Labs is pleased to offer tailored packages for organisations seeking to test their staff for COVID-19.
-
Diagnostic testing for gestational diabetes mellitus (GDM) during the COVID-19 pandemic: Antenatal and postnatal testing advice
During the COVID-19 pandemic, temporary changes to the recommended process of diagnostic testing for GDM during pregnancy and for postnatal testing in women who have had GDM may be required. Local health care institutions should make the decision about the appropriate GDM testing protocol for their local population based on demographic factors and local public health data regarding the risk of COVID-19 exposure.
-
Telehealth Consultations
Information for doctors on Telehealth Consultations including our electronic pathology request form
